Skip to main content
. 2024 Jul 16;57(1):267–279. doi: 10.4143/crt.2024.479

Table 4.

Treatment-emergent adverse events

Adverse event Grade 1-2 Grade 3 Grade 4
Hematologic events
 Thrombocytopenia 2 (6.9) 0 1 (3.4)
 Neutropenia 1 (3.4) 0 0
 Anemia 4 (13.8) 0 0
Gastrointestinal events
 Diarrhea 3 (10.3) 1 (3.4) 0
 Nausea 4 (13.8) 0 0
Neurologic events
 Peripheral neuropathy 6 (20.7) 0 0
 Seizure 1 (3.4) 0 0
Infections
 Pneumonia 0 1 (3.4) 0
 Eye infection 2 (6.9) 0 0
 Skin infection 0 1 (3.4) 0
 Upper respiratory tract infection 3 (10.3) 0 0
Other conditions
 Fatigue 5 (17.2) 0 0
 Skin rash 5 (17.2) 0 0
 Pyrexia 4 (13.8) 0 0
 Elevated aminotransferase 2 (6.9) 0 0
 Hypertension 2 (6.9) 0 0

Values are presented as number (%).